跳至主要内容
临床试验/CTRI/2023/05/053108
CTRI/2023/05/053108招募中Unknown

Efficacy and Safety of Once Daily Regimen of Fixed Dose Combination of Vildagliptin SR and Metformin SR (Verifica M OD) in Treatment of Diabetes Mellitus

D Y Patil University School of Medicine0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age >18 years of age.
  • 2.Males and females.
  • 3.Patients having T2DM as per the criteria by the ADA with any one of the following two
  • -Treatment naïve patients of T2DM, OR
  • -Known patients of T2DM uncontrolled by existing anti-diabetic therapy.

排除标准

  • 1.Type-1 diabetes mellitus.
  • 2.Gestational diabetes.
  • 3.Pancreatic Diabetes or Diabetes in the Context of Disease of the Exocrine Pancreas.
  • 4.Post-transplantation Diabetes Mellitus.
  • 5.Any reported evidence of malignancy.
  • 6.Reports suggestive of any metabolic diseases.
  • 7.Patients with moderate or severe renal impairment or with end-stage renal disease (ESRD)
  • 8.Patients with hepatic impairment
  • 9.Previously known hypersensitivity

研究者

发起方
D Y Patil University School of Medicine

相似试验